A new policy clash is emerging at the crossroads of cannabis reform and gun rights, as a prominent Second Amendment advocacy group is calling on federal regulators to rethink long-standing restrictions that bar legal cannabis consumers from owning firearms.
Following the federal government’s recent decision to reclassify marijuana under the Controlled Substances Act, Gun Owners of America is urging the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) to update its enforcement posture. The group argues that Americans who legally consume cannabis under state law should no longer be treated as “unlawful users of controlled substances,” a label that has historically stripped them of their right to possess firearms.
For decades, marijuana’s placement in the most restrictive federal drug category created a legal contradiction. Even as states rolled out regulated medical and adult-use cannabis programs, federal law continued to lump marijuana users into the same category as those engaged in illegal drug activity. That classification triggered automatic disqualification under federal gun laws, forcing otherwise law-abiding citizens to choose between lawful cannabis use and their Second Amendment rights.
The recent rescheduling of cannabis has reopened the debate. Gun rights advocates say the federal government can no longer justify treating state-authorized cannabis consumers as prohibited persons, especially when the drug is now recognized as having accepted medical uses and a lower potential for abuse than previously claimed.
The issue has already made its way through the courts, with several judges questioning whether banning firearm possession solely on the basis of cannabis use aligns with constitutional protections. Those rulings, combined with the federal policy shift, have added pressure on regulators to clarify how — or if — the old rules should still apply.
At its core, the argument is about consistency. Supporters of reform contend that citizens following state cannabis laws should not be subjected to federal penalties that no longer reflect current science, policy, or public opinion. Critics, meanwhile, caution that any changes must still prioritize public safety.
As federal agencies weigh their next steps, one thing is clear: cannabis reform is no longer confined to dispensaries and doctors’ offices. Its ripple effects are now reaching some of the most fiercely defended terrain in American law — and the outcome could redefine how two highly politicized rights coexist in a rapidly changing legal landscape.
Dabbin-Dad Newsroom
